Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Journal of Clinical Investigation

• Publication date

  1998-02-15

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1172/JCI119883PMID 9466976PMCID PMC508629
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression of inducible nitric oxide synthase in human heart failure.

  1997cited by this paper
• cGMP-elevating agents suppress proliferation of vascular smooth muscle cells by inhibiting the activation of epidermal growth factor signaling pathway.

  1997cited by this paper
• Atrial natriuretic peptide induces apoptosis in neonatal rat cardiac myocytes.

  1996cited by this paper
• Expression of inducible nitric oxide synthase in human heart failure.

  1996cited by this paper
• Extracellular ATP inhibits adrenergic agonist-induced hypertrophy of neonatal cardiac myocytes.

  1996cited by this paper
• Chronic L-arginine administration attenuates cardiac hypertrophy in spontaneously hypertensive rats.

  1996cited by this paper
• Interleukin-1 beta modulates the growth and phenotype of neonatal rat cardiac myocytes.

  1995cited by this paper
• Effects of Interleukin-1β and Nitric Oxide on Cardiac Myocytes

  1995cited by this paper
• Cyclic GMP‐mediated inhibition of L‐type Ca2+ channel activity by human natriuretic peptide in rabbit heart cells

  1995cited by this paper
• Divergent pathways mediate the induction of ANF transgenes in neonatal and hypertrophic ventricular myocardium.

  1995cited by this paper
• Gene expression of natriuretic peptide receptors in myocardial cells.

  1995cited by this paper
• Natriuretic peptides inhibit DNA synthesis in cardiac fibroblasts.

  1995cited by this paper
• Nitric oxide donor SIN-1 inhibits mammalian cardiac calcium current through cGMP-dependent protein kinase.

  1995cited by this paper
• Pressure- and volume-induced left ventricular hypertrophies are associated with distinct myocyte phenotypes and differential induction of peptide growth factor mRNAs.

  1995cited by this paper
• Nitric oxide-generating compounds inhibit total protein and collagen synthesis in cultured vascular smooth muscle cells.

  1995cited by this paper
• Effects of interleukin-1 beta and nitric oxide on cardiac myocytes.

  1995cited by this paper
• Regulation of rat ventricular myosin heavy chain expression by serum and contractile activity.

  1994cited by this paper
• Autocrine and paracrine effects of atrial natriuretic peptide gene transfer on vascular smooth muscle and endothelial cellular growth.

  1994cited by this paper
• Involvement of protein kianse C and Ca2+ in angiotensin II-induced mitogenesis of cardiac fibroblasts.

  1994cited by this paper
• Cloning of the rat alpha 1C-adrenergic receptor from cardiac myocytes. alpha 1C, alpha 1B, and alpha 1D mRNAs are present in cardiac myocytes but not in cardiac fibroblasts.

  1994cited by this paper
• The L-type calcium channel current is increased by alpha-1 adrenoceptor activation in neonatal rat ventricular cells.

  1994cited by this paper
• Hypertrophic stimuli induce transforming growth factor-beta 1 expression in rat ventricular myocytes.

  1994cited by this paper
• Cloning of the rat alpha 1C-adrenergic receptor from cardiac myocytes. alpha 1C, alpha 1B, and alpha 1D mRNAs are present in cardiac myocytes but not in cardiac fibroblasts.

  1994cited by this paper
• Transforming growth factor beta-1 modulates the number of beta-adrenergic receptors in cardiac fibroblasts.

  1994cited by this paper
• Transforming growth factor beta-1 modulates the number of beta-adrenergic receptors in cardiac fibroblasts.

  1994cited by this paper
• Angiotensin II is mitogenic in neonatal rat cardiac fibroblasts.

  1993cited by this paper
• Beta-adrenergic stimulation of cardiac non-myocytes augments the growth-promoting activity of non-myocyte conditioned medium.

  1993influential reference
• The alpha 1A-adrenergic receptor subtype mediates biochemical, molecular, and morphologic features of cultured myocardial cell hypertrophy.

  1993cited by this paper
• Interaction of PDGF and natriuretic peptides on mesangial cell proliferation and endothelin secretion.

  1993cited by this paper
• Control of cardiac muscle cell function by an endogenous nitric oxide signaling system.

  1993cited by this paper
• Molecular characterization of angiotensin II--induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype.

  1993cited by this paper
• Nitric oxide attenuates cardiac myocyte contraction.

  1993cited by this paper
• Cyclic GMP inhibits the inotropic response to alpha 1-adrenoceptors in the papillary muscle of the ferret.

  1992cited by this paper
• Induction and potential biological relevance of a Ca2+‐independent nitric oxide synthase in the myocardium

  1992cited by this paper
• Natriuretic peptide receptor mRNAs in the rat and human heart.

  1992cited by this paper
• Clearance receptor-binding atrial natriuretic peptides inhibit mitogenesis and proliferation of rat aortic smooth muscle cells.

  1991cited by this paper
• Adrenergic regulation of the skeletal alpha-actin gene promoter during myocardial cell hypertrophy.

  1991cited by this paper
• Effect of norepinephrine on myocardial collagen gene expression and response of cardiac fibroblasts after norepinephrine treatment.

  1991cited by this paper
• Natriuretic peptides inhibit rat astroglial proliferation: mediation by C receptor.

  1991cited by this paper
• Ca2+ current is regulated by cyclic GMP-dependent protein kinase in mammalian cardiac myocytes.

  1991cited by this paper
• The alpha-adrenergic stimulation of atrial natriuretic factor expression in cardiac myocytes requires calcium influx, protein kinase C, and calmodulin-regulated pathways.

  1991cited by this paper
• Effect of atriopeptin II on Ca influx, contractile behavior and cyclic nucleotide content of cultured neonatal rat myocardial cells.

  1990cited by this paper
• Alpha 1-adrenergic receptor mRNA level is regulated by norepinephrine in rabbit aortic smooth muscle cells.

  1990cited by this paper
• Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells.

  1989cited by this paper
• Norepinephrine-stimulated hypertrophy of cultured rat myocardial cells is an alpha 1 adrenergic response.

  1983cited by this paper

• Molecular Mechanisms Underlying Heart Failure and Their Therapeutic Potential

  2025cites this paper
• Evaluating the Reparative Potential of Secretome from Patient-Derived Induced Pluripotent Stem Cells during Ischemia–Reperfusion Injury in Human Cardiomyocytes

  2024cites this paper
• Cardiovascular Effects of Stimulators of Soluble Guanylate Cyclase Administration: A Meta-analysis of Randomized Controlled Trials

  2024cites this paper
• Identification and Verification of Potential Markers Related to Myocardial Fibrosis by Bioinformatics Analysis

  2024cites this paper
• The role of cardiac microenvironment in cardiovascular diseases: implications for therapy

  2024cites this paper
• Natriuretic peptides potentiate cardiac hypertrophic response to noradrenaline in rats.

  2023cites this paper
• Integrin αV mediated activation of myofibroblast via mechanoparacrine of transforming growth factor β1 in promoting fibrous scar formation after myocardial infarction.

  2023cites this paper
• Augmentation of natriuretic peptide (NP) receptor A and B (NPR-A and NPR-B) and cyclic guanosine monophosphate (cGMP) signalling as a therapeutic strategy in heart failure

  2023cites this paper
• Gβγ subunits co-localize with RNA polymerase II and regulate transcription in cardiac fibroblasts.

  2023cites this paper
• Biomarkers in heart failure: a focus on natriuretic peptides

  2023cites this paper
• The Microenvironment of the Pathogenesis of Cardiac Hypertrophy

  2023cites this paper
• The neuropeptide substance P/neurokinin‐1 receptor system and diabetes: From mechanism to therapy

  2023cites this paper
• The NO-cGMP-PKG Axis in HFpEF: From Pathological Mechanisms to Potential Therapies

  2023cites this paper
• Hyperuricemia is associated with heart failure readmission in patients with heart failure and preserved ejection fraction-an observational study in Chinese.

  2023cites this paper
• Neferine attenuates doxorubicin‐induced fibrosis and hypertrophy in H9c2 cells

  2022cites this paper
• Role of Cardiac Natriuretic Peptides in Heart Structure and Function

  2022cites this paper
• Signaling cascades in the failing heart and emerging therapeutic strategies

  2022cites this paper
• Comparing the signaling and transcriptome profiling landscapes of human iPSC-derived and primary rat neonatal cardiomyocytes

  2022cites this paper
• Preoperative Liver Stiffness is Associated With Hospital Length of Stay After Cardiac Surgery.

  2022cites this paper
• Thymosin β4 Protects against Cardiac Damage and Subsequent Cardiac Fibrosis in Mice with Myocardial Infarction

  2022cites this paper
• Atrial fibrosis and substrate based characterization in atrial fibrillation: Time to move forwards

  2021cites this paper
• Novel Insights Regarding Nitric Oxide and Cardiovascular Diseases

  2021cites this paper
• Predominance of Heart Failure With Preserved Ejection Fraction in Postmenopausal Women: Intra- and Extra-Cardiomyocyte Maladaptive Alterations Scaffolded by Estrogen Deficiency

  2021cites this paper
• Toward a New Paradigm for Targeted Natriuretic Peptide Enhancement in Heart Failure

  2021cites this paper
• Interaction among Hydrogen Sulfide and Other Gasotransmitters in Mammalian Physiology and Pathophysiology.

  2021cites this paper
• Lipotoxicity: a driver of heart failure with preserved ejection fraction?

  2021cites this paper
• Cardiac fibrosis.

  2020cites this paper
• Vasonatrin peptide, a synthetic natriuretic peptide, attenuates myocardial injury and oxidative stress in isoprenaline-induced cardiomyocyte hypertrophy.

  2020cites this paper
• What Is the Role of the Inflammation in the Pathogenesis of Heart Failure?

  2020cites this paper
• cGMP Signaling and Modulation in Heart Failure.

  2020cites this paper
• Cardiovascular Therapeutic Potential of the Redox Siblings, Nitric Oxide (NO•) and Nitroxyl (HNO), in the Setting of Reactive Oxygen Species Dysregulation.

  2020cites this paper
• Multiplicity of Nitric Oxide and Natriuretic Peptide Signalling in Heart Failure.

  2020cites this paper
• Full Issue PDF

  2020cites this paper
• Natriuretic peptides and neprilysin inhibition in hypertension and hypertensive organ damage.

  2020cites this paper
• Targeting cardiac fibrosis in heart failure with preserved ejection fraction: mirage or miracle?

  2020cites this paper
• Differential Effects of Sacubitril/Valsartan on Diastolic Function in Mice With Obesity-Related Metabolic Heart Disease

  2020cites this paper
• The long and winding road of designing phosphodiesterase inhibitors for the treatment of heart failure.

  2020cites this paper
• Elevated plasma levels of asymmetric dimethylarginine and the risk for arrhythmic death in ischemic and non-ischemic, dilated cardiomyopathy - a prospective, controlled long-term study.

  2020cites this paper
• Cardiac Cyclic Nucleotide Phosphodiesterases: Roles and Therapeutic Potential in Heart Failure

  2020cites this paper
• Differential Activation of P-TEFb Complexes in the Development of Cardiomyocyte Hypertrophy following Activation of Distinct G Protein-Coupled Receptors

  2020cites this paper
• Heart failure with preserved ejection fraction: Similarities and differences between women and men.

  2020cites this paper
• Ischemic Heart Disease and Heart Failure: Role of Coronary Ion Channels

  2020cites this paper
• Neuroinflammation in heart failure: new insights for an old disease

  2019cites this paper
• Transcriptomic Research in Heart Failure with Preserved Ejection Fraction: Current State and Future Perspectives

  2019influential citation
• Role of endothelial dysfunction in heart failure

  2019cites this paper
• Genetic Ablation and Guanylyl Cyclase/Natriuretic Peptide Receptor-A: Impact on the Pathophysiology of Cardiovascular Dysfunction

  2019cites this paper
• TGR5 activation ameliorates hyperglycemia-induced cardiac hypertrophy in H9c2 cells

  2019cites this paper
• Cardiovascular Pleiotropic Effects of Natriuretic Peptides

  2019cites this paper
• Atrial Natriuretic Peptide: A Molecular Target of Novel Therapeutic Approaches to Cardio-Metabolic Disease

  2019cites this paper
• Novel Mechanisms in Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction

  2019cites this paper
• Left Ventricular Myocardial Performance in Normotensive Offspring of Hypertensive Parents

  2019cites this paper
• Natriuretic Peptides in Heart Failure with Preserved Left Ventricular Ejection Fraction: From Molecular Evidences to Clinical Implications

  2019cites this paper
• Antihypertrophic Effects of Nebivolol on Neonatal Cardiomyocyte Hypertrophy Models

  2019cites this paper
• Ischemia Reperfusion Injury Produces, and Ischemic Preconditioning Prevents, Rat Cardiac Fibroblast Differentiation: Role of KATP Channels

  2019cites this paper
• Prognostic Value of Serum Uric Acid in Hospitalized Heart Failure Patients With Preserved Ejection Fraction (from the Japanese Nationwide Multicenter Registry).

  2019cites this paper
• Combination of Plasma Biomarkers and Clinical Data for the Detection of Myocardial Fibrosis or Aggravation of Heart Failure Symptoms in Heart Failure with Preserved Ejection Fraction Patients

  2018cites this paper
• The β subunit of soluble guanylyl cyclase GUCY1B3 exerts cardioprotective effects against ischemic injury via the PKCε/Akt pathway

  2018cites this paper
• Phosphodiesterase 2 inhibition preferentially promotes NO/guanylyl cyclase/cGMP signaling to reverse the development of heart failure

  2018cites this paper
• CANCER THERAPY

  2018cites this paper
• Synthesis, secretion, function, metabolism and application of natriuretic peptides in heart failure

  2018cites this paper
• Regulation of Transplanted Cell Homing by FGF1 and PDGFB after Doxorubicin Myocardial Injury

  2018cites this paper
• Combination of Hydralazine and Isosorbide-Dinitrate in the Treatment of Patients with Heart Failure with Reduced Ejection Fraction.

  2018cites this paper
• Signalling Microdomains: The Beta-3 Adrenergic Receptor/NOS Signalosome

  2017cites this paper
• Evaluation and Management of Heart Failure

  2017cites this paper
• The opposing roles of NO and oxidative stress in cardiovascular disease.

  2017cites this paper
• The renal and cardiovascular effects of natriuretic peptides.

  2017cites this paper
• Cardioprotective effects of curcumin-loaded magnetic hydrogel nanocomposite (nanocurcumin) against doxorubicin-induced cardiac toxicity in rat cardiomyocyte cell lines

  2017cites this paper
• Microdomains in the Cardiovascular System

  2017cites this paper
• Compartmentation of Natriuretic Peptide Signalling in Cardiac Myocytes: Effects on Cardiac Contractility and Hypertrophy

  2017cites this paper
• Cyclic nucleotide imaging and cardiovascular disease.

  2017cites this paper
• The associations among co-morbidity, cardiac geometries and mechanics in hospitalized heart failure with or without preserved ejection fraction

  2017cites this paper
• Astragalus polysaccharide ameliorates H2O2-induced human umbilical vein endothelial cell injury

  2017cites this paper
• Natriuretic peptide receptor-C activation regulates vascular smooth muscle cell hypertrophy : molecular mechanisms

  2017cites this paper
• Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition

  2016cites this paper
• Enhanced expression of endothelial nitric oxide synthase in the myocardium ameliorates the progression of left ventricular hypertrophy in L-arginine treated Wistar-Kyoto rats.

  2016cites this paper
• March 15 , 2016 by blocking vascular and adrenal

  2016cites this paper
• Waon therapy attenuates cardiac hypertrophy and promotes myocardial capillary growth in hypertensive rats: a comparative study with fluvastatin

  2016influential citation
• Effects of inhibitory G protein upon muscarinic and ß-adrenergic signaling in the failing heart

  2016cites this paper
• Mechanisms of Lipid Accumulation in the Bone Morphogenetic Protein Receptor Type 2 Mutant Right Ventricle.

  2016cites this paper
• Protective effects of Astragalus polysaccharides against endothelial dysfunction in hypertrophic rats induced by isoproterenol.

  2016cites this paper
• Somatic Mutation Theory - Why it's Wrong for Most Cancers

  2016cites this paper
• inhibits cyclin E transcription and mesangial cell cycle Overexpression of protein kinase G using adenovirus

  2016cites this paper
• Retinoic acid and sodium butyrate suppress the cardiac expression of hypertrophic markers and proinflammatory mediators in Npr1 gene-disrupted haplotype mice.

  2016cites this paper
• Nitrates for the prevention of cardiac morbidity and mortality in patients undergoing non-cardiac surgery.

  2016cites this paper
• Investigation of Biochemical Composition and Vasomotor Effect of Human Pericardial Fluid

  2016cites this paper
• Implications physiopathologiques de la Nestine lors du remodelage pulmonaire et cardiaque à la suite de l’infarctus du myocarde, du diabète et de l’hypertension pulmonaire

  2016cites this paper
• Human Endomyocardial Biopsy Specimen‐Derived Stromal Cells Modulate Angiotensin II‐Induced Cardiac Remodeling

  2016cites this paper
• Periodontitis and myocardial hypertrophy

  2016cites this paper
• Mechanisms of dyspnoea and poor exercise tolerance in a representative cohort of elderly patients with a relatively normal ejection fraction on echocardiography

  2016cites this paper
• The Role of β-adrenergic Signalling and Natriuretic Peptide Receptors in Cardiac Myofibroblast Proliferation and Differentiation

  2016influential citation
• Chronic Hypobaric Hypoxia Induces Right Ventricular Hypertrophy and Apoptosis in Rats: Therapeutic Potential of Nanocurcumin in Improving Adaptation

  2016cites this paper
• Increased mitochondrial prooxidant activity mediates up-regulation of Complex I S-glutathionylation via protein thiyl radical in the murine heart of eNOS(-/-).

  2015cites this paper
• Isosorbide Dinitrate Inhibits Mechanical Stress-induced Cardiac Hypertrophy and Autophagy Through Downregulation of Angiotensin II Type 1 Receptor

  2015cites this paper
• The role of glycogen synthase kinase-3 and camp response element-binding protein in the induction and regulation of cardiac hypertrophy in neonatal rat ventricular myocytes

  2015cites this paper
• Targeted deletion of Tsc1 causes fatal cardiomyocyte hyperplasia independently of afterload.

  2015cites this paper
• Augmented endothelial l‐arginine transport ameliorates pressure‐overload‐induced cardiac hypertrophy

  2015cites this paper
• Nitric Oxide‐cGMP‐PKG Pathway Acts on Orai1 to Inhibit the Hypertrophy of Human Embryonic Stem Cell‐Derived Cardiomyocytes

  2015cites this paper
• Natriuretic Peptides in the Regulation of Cardiovascular Physiology and Metabolic Events

  2015cites this paper
• The natriuretic peptides system in the pathophysiology of heart failure: from molecular basis to treatment

  2015cites this paper
• Hepatic Stellate Cells and Hepatocyte Survival

  2015cites this paper